Teriparatide is the recombinant N-terminal fragment 1-34 of human parathyroid hormone (PTH). It is regulatory-approved and studied in the scientific literature as a bone-anabolic agent for the treatment of osteoporosis. Unlike antiresorptive agents, studies attribute to it an effect that stimulates new bone formation.
Teriparatide corresponds to the biologically active first 34 amino acids of human parathyroid hormone and binds the PTH-1 receptor on bone and kidney cells. The literature describes that intermittent receptor activation preferentially stimulates the activity of bone-forming osteoblasts, whereas continuously elevated PTH exposure (as in hyperparathyroidism) tends to favor bone resorption. This time-dependent difference is regarded as the mechanistic basis for the bone-anabolic effect observed in studies.
Curva teorica di concentrazione con un'emivita di 1 h. Modello puramente farmacocinetico — non una raccomandazione di dose.
Open in PK tool →I peptidi arrivano come polvere secca. Una volta disciolti in un liquido (ricostituzione), questo calcolatore risponde a una sola domanda: quanta sostanza c'è in un millilitro di soluzione dopo?
Questi cofattori si riferiscono alla classe del peptide, non a un uso specifico. Nessuna raccomandazione, nessun dosaggio.
Solo scienza, nessuna vendita. Disiscriviti quando vuoi.
We store your email only for the newsletter. Unsubscribe anytime. Privacy